Biological Therapy Analysis & Statistics, November 2014 (p4)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: Flow Cytometry, Hematology, Stem Cell, more »

91-120 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Tissue Therapies Ltd

Tissue Therapies Ltd

  • $ 55
  • Company report
  • November 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Tissue Therapies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
Bioheart, Incorporation

Bioheart, Incorporation

  • $ 55
  • Company report
  • November 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Bioheart, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biological Therapy
Shanghai Jiaoda Onlly Co., Ltd.

Shanghai Jiaoda Onlly Co., Ltd.

  • $ 55
  • Company report
  • November 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Shanghai Jiaoda Onlly Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy
Bone Regeneration - Pipeline Review, H2 2014

Bone Regeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World
Global and China Stem Cell Industry Report, 2014-2017

Global and China Stem Cell Industry Report, 2014-2017

  • $ 2 250
  • Industry report
  • September 2014
  • by Research In China

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment ...

  • Industries : Biological Therapy
  • Countries : China, World
Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...

  • Industries : Biological Therapy
  • Countries : United States
Global Gene Therapy Market Outlook 2018

Global Gene Therapy Market Outlook 2018

  • $ 1 500
  • Industry report
  • September 2014
  • by RNCOS

Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the ...

  • Industries : Biological Therapy
  • Countries : World
Tissue Engineering and Regeneration: Technologies and Global Markets

Tissue Engineering and Regeneration: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

This BCC Research report presents an in-depth analysis of the global tissue engineering and regeneration market by technologies, materials, applications segments and regional markets. It includes comprehensive ...

  • Industries : Biological Therapy
  • Countries : World
Ophthalmics Partnering Terms & Agreements

Ophthalmics Partnering Terms & Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Opthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter opthalmics partnering deals. The majority of deals are discovery, preclinical ...

  • Industries : Biological Therapy
Cell Therapy Deals and Alliances of 2013

Cell Therapy Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Cell Therapy Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Biological Therapy
 B-Cell Leukemia-Pipeline Insights, 2014

B-Cell Leukemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ B-Cell Leukemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Biological Therapy
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the ...

  • Industries : Biological Therapy
The Global Market for Stem Cells

The Global Market for Stem Cells

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research report provides detailed market, technology, and industry analyses to quantify and qualify the global market for prescription drug products. Important trends are identified and sales ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe, India, Canada, Germany, Japan, China, Brazil, Spain, Italy, France, Asia, Mexico, North America, United Kingdom
Histocell S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Histocell S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Histocell S.L. (Histocell) is a biopharmaceutical company. The company develops cell therapy and tissue engineering products for regenerative medicine. It offers contract manufacturing services, ...

  • Industries : Biological Therapy
DiscoveryBiomed, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DiscoveryBiomed, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary DiscoveryBiomed, Inc. (DBM) is a life sciences and biotechnology company. The company discovers and develops human cell based drugs. It offers products in three segments, such as cell cultures, ...

  • Industries : Biological Therapy
  • Countries : United States
Cell Medica Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cell Medica Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Cell Medica Limited (Cell Medica) is a biotechnology company. The company develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. It has developed ...

  • Industries : Biological Therapy
CMC Biologics AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CMC Biologics AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary CMC Biologics A/S (CMC Biologics) is a contract biopharmaceutical manufacturing and development company. It provides manufacturing services for DNA, active pharmaceutical ingredient (APIs), and ...

  • Industries : Biological Therapy
Cyntellect, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cyntellect, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Cyntellect, Inc. (Cyntellect) is a life science company based in the US. The company provides standards for advancing the fields of cell analysis. Its products include celigo and c-lect consumables. ...

  • Industries : Biological Therapy
  • Countries : United States
Chemokine Therapeutics Corp. (CTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chemokine Therapeutics Corp. (CTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and ...

  • Industries : Biological Therapy
  • Countries : Canada, United Kingdom
Cellartis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cellartis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Cellartis AB (Cellartis) is a biotechnology company. The company provides pluripotent stem cells and human embryonic stem cells, and technology for drug discovery research, toxicity testing and ...

  • Industries : Biological Therapy
  • Countries : United States
Lentigen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Lentigen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Lentigen Corporation (Lentigen) is a biotechnology company. The company develops and commercializes lentiviral vector technology for a range of therapeutic, vaccine, and bioproduction applications. ...

  • Industries : Biological Therapy
  • Countries : United States
Mesoblast Limited (MSB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesoblast Limited (MSB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Mesoblast Limited (Mesoblast) is a biotechnology company. It focuses on developing novel biotherapeutics using its cell-based technologies for the treatment of a wide range of diseases. The company's ...

  • Industries : Biological Therapy
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2014

GM-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biological Therapy
Anti GM-CSF Antibody -Pipeline Insights, 2014

Anti GM-CSF Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti GM-CSF Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2014

Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Broad Spectrum Chemokine Inhibitors (BSCIs)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy
B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2014

B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“B-Cell Activating Factor (BAFF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy
CD4+ T cell Activators -Pipeline Insights, 2014

CD4+ T cell Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“CD4+ T cell Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
CD8+ T cell Activators -Pipeline Insights, 2014

CD8+ T cell Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“CD8+ T cell Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Biological Therapy

33 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

Aastrom Biosciences Inc.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.